The transaction is valued at €337 million in cash, subject to adjustments upon completion, according to a statement. The deal is expected to generate a capital gain to be determined at closing.
Generali Spain will retain €51 million in excess capital currently allocated to the Irish P&C operations.
The transaction will have a negligible impact on normalized EPS and an estimated positive impact of approximately 1 percentage point on the group's Solvency II Ratio, the statement added.
Full press release
(Claudia Cristoferi, editing Sabina Suzzi)




















